FOSUN HEALTH Logo

Brain Metastases FAQ

catalogue

Brain Metastases FAQ

Brain Metastases FAQ

The questions on this page come after the medical ones have been answered — what treatment will cost, how long the patient will be away from home, which drugs can actually be given here, and what happens on return. They are answered separately on purpose, because the treatment of this condition spans two specialties and several phases, and the phases do not all have to take place in the same country.

What treatment costs

Treatment in China typically costs 30% to 50% of the equivalent in Europe or the United States. The total depends on which parts of the pathway are needed:

  • Imaging and assessment — contrast-enhanced MRI of the brain with the additional sequences used for planning, the review of pathology and molecular testing, and the imaging of the body that records the state of the disease elsewhere.
  • Focused radiotherapy — stereotactic radiosurgery or fractionated stereotactic treatment, priced by the plan and the number of sessions rather than by the minute, including the planning scans and the immobilisation device.
  • Surgery — the operation itself, including the imaging and monitoring used to plan it, and the intensive care that some patients need afterwards.
  • Drug treatment — targeted agents and immunotherapy are the largest recurring item and are counted monthly, together with the monitoring they require and the steroids and anti-epileptic drugs used alongside.

How long you will need to stay

The length of a stay is determined by which part of the treatment you are in, and the parts differ a great deal in duration:

  • Assessment and planning — usually about one week, including the brain imaging and the review of pathology and molecular results.
  • Focused radiotherapy — often a single session for stereotactic radiosurgery, or a small number of sessions when the dose is divided; most patients are treated as outpatients.
  • Surgery — an inpatient stay of roughly one to two weeks, longer if intensive care or early rehabilitation is needed.
  • Whole-brain radiotherapy — a course of daily outpatient treatment over one to two weeks, during which most patients stay nearby and attend each weekday.
  • Drug treatment — taken at home with blood tests and imaging at intervals, and this phase can be supervised locally with results sent to us.

Which medicines are available

Most medicines used in this condition internationally are available here, and the relevant ones depend on the type of cancer:

  • Targeted agents for lung cancer — the EGFR, ALK and ROS1 inhibitor classes, which are among the drugs that reach the brain effectively and are often central to treatment when a deposit is present.
  • HER2-directed treatment for breast cancer, including the classes used when the cancer has spread to the brain.
  • BRAF and MEK inhibitors for melanoma, and immune checkpoint inhibitors, both of which have activity in the brain in that cancer.
  • Immune checkpoint inhibitors more generally, where the tumour type and its markers make them relevant.
  • Steroids and anti-epileptic drugs, including the range needed to control swelling and seizures, with attention to interactions between them.

Sending records and receiving a written opinion

The most useful thing to send is the original documents and the images rather than a summary:

  • The pathology report with the molecular results from the cancer that first appeared, together with any report from tissue taken from the brain. This is the document that decides which drug options apply.
  • The MRI images themselves, or a link to them, for every brain scan that has been done. The reports describe the scans, but the comparison that decides treatment is made on the images.
  • The record of treatment already given — operations, radiotherapy with dose and dates, and drug treatment with what was used for how long and how the cancer responded.
  • The most recent imaging of the chest and abdomen, or a whole-body scan, which records how the disease outside the brain is behaving.
  • The current medication list, including steroids with their dose and how it has changed, anti-epileptic drugs, and anything taken without prescription.

Insurance and payment

Coverage needs checking in specific terms here, because the treatment is spread across several settings and several specialties:

  • Check whether the policy covers treatment outside your country of residence before assuming it does, and whether prior authorisation is required for each phase separately.
  • Check surgical and intensive care cover specifically, since an operation followed by time in intensive care costs very differently from the operation alone.
  • Check the drug cover carefully, since targeted agents and immunotherapies are the largest recurring cost, are priced monthly, and are often handled under a separate benefit from hospital care.
  • Ask whether direct billing is available for your insurer, and request the documentation they need at the outset — a treatment plan, an itemised estimate and clinical justification take time to assemble.

After treatment, and back home

Because this condition is managed across the whole body, the handover document matters more here than in most:

  • A written summary of what was actually done — the treatment given to the brain and its date, the drug treatment with doses and start dates, and the imaging taken at the end of each phase.
  • An imaging schedule with defined intervals, stating when the next brain scan is due, when the body imaging is due, and what change would prompt an earlier scan.
  • The steroid plan — the current dose, the intended reduction, and the symptoms that would mean it should be reviewed rather than continued.
  • Seizure and medication guidance, including how the anti-epileptic drugs interact with the cancer treatment, and what the safety advice is about driving and other activities.
  • A rehabilitation programme to continue locally, with the goals stated, since functional recovery continues for months after treatment.
  • A named contact for questions between scans, and the arrangement for images taken locally to be reviewed remotely.

Eating, activity and daily life during treatment

No diet treats a cancer that has spread to the brain. What nutrition and daily life can do is support you through treatment and protect function:

  • Adequate protein and calories to maintain weight, because steroids increase appetite and blood sugar while treatment increases the body's needs.
  • Food safety during treatment — avoiding unpasteurised dairy, raw or undercooked meat, eggs and seafood, and unwashed produce, since the blood count may be suppressed.
  • Activity adapted to function — guided by physiotherapy, because keeping moving reduces the risk of clots and supports recovery, while seizure control and balance may limit what is safe.

Frequently Asked Questions

How much does treatment for cancer in the brain cost in China?

Treatment in China typically costs 30% to 50% of the equivalent in Europe or the United States. The total depends on the phases you need: imaging and assessment, focused radiotherapy priced by the plan and the number of sessions, an operation with intensive care where it applies, whole-brain radiotherapy priced as a course, and drug treatment counted monthly together with monitoring and supportive medication. Targeted agents and immunotherapies are the largest recurring item, so it is worth asking for the drug phase of the estimate separately. A formal itemised estimate is prepared from your own records and the proposed plan.

How long will I need to stay in China?

It depends on the treatment. Assessment and planning usually take about a week. Focused radiotherapy is often a single session, or a small number if the dose is divided, and is usually done as an outpatient. An operation involves one to two weeks in hospital, longer if intensive care or early rehabilitation is needed. Whole-brain radiotherapy runs over one to two weeks of daily outpatient treatment. Drug treatment is taken at home with monitoring, and that phase can be supervised locally with results sent to us rather than requiring a stay.

Are the same drugs available as in my own country?

Most of the drugs used in this condition are available in our network, including the targeted agents for lung cancer, HER2-directed treatment for breast cancer, BRAF and MEK inhibitors and immunotherapies for melanoma, and the steroids and anti-epileptic drugs used alongside. Availability of a specific product depends on the hospital and the indication, so it should be confirmed in writing as part of the plan. Where an agent approved elsewhere is not available, it is worth asking what the realistic alternative is — usually another drug of the same class, and the substitution is routine rather than exceptional.

What should I bring, and what should I take home?

Bring the pathology report with the molecular results from the original cancer, any report from tissue taken from the brain, all brain MRI images or links to them, the record of treatment already given with doses and dates, and the current medication including steroids. Take home a written summary of what was done, an imaging schedule with dates for both the brain and the body, the steroid reduction plan, seizure and medication guidance including safety advice, and a rehabilitation programme to continue locally. In a condition monitored over months, the record is the most useful document you can hold.

Can follow-up be done remotely after I return home?

Partly, and it is worth planning for. Reviewing imaging, adjusting medication, and deciding when the next scan is due can all be done remotely, arranged through a named contact rather than a general enquiry line. A scan taken locally can be sent to us for comparison with the previous study, which is how most patients conduct the long monitoring phase while continuing treatment close to home. Anything requiring an examination, a procedure, a radiotherapy session or further surgery has to be done in person, and those points should be identified in advance so that travel can be planned.

What if the cancer in the brain gets worse?

There is usually a defined next step rather than a single standard one. If a change appears on the scan soon after radiotherapy, the first question is whether it represents growth or the effect of treatment on the tissue, which is settled with additional imaging sequences or a repeat scan at a short interval. If it is growth, the options include further focused radiotherapy where the site and previous dose allow, a change of drug treatment, an operation where the deposit is accessible and causing pressure, or renewed attention to symptom control. Retesting the molecular markers at that point is increasingly worthwhile, because a cancer can acquire new findings that make a treatment relevant which was not before.

Ask before you commit to a treatment plan

Send the pathology and molecular reports, the brain MRI images and reports with dates, the record of treatment already given, and the current medication including steroids. Our international patient team will return a written assessment within 48 hours of the file being complete, with an itemised estimate on request.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*